Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Simple methods using DHT levels effectively assess compliance.

Expanding premarital screening to include skin conditions, STDs, infertility, and male disorders can improve marriage stability.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Polygenic Score can help predict severe psoriasis and psoriatic arthritis.

Teens with PCOS have a higher risk of type 2 diabetes and need regular glucose checks.

Self-management can help improve symptoms of benign prostatic hyperplasia.

Early detection of apolipoprotein levels helps reduce depression risk in the elderly.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

PSI-MS quickly and accurately measures finasteride in tablets, helping with quality control.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Consider Sertoli-Leydig cell tumors in Peutz-Jeghers syndrome patients with adnexal masses.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Taking photos of your own skin can lead to fewer skin biopsies for mole monitoring.

Accurate diagnosis of progressive supranuclear palsy requires thorough neurological assessments and MRI.

CEC levels may be a useful marker for predicting prostate cancer progression.

Primary care doctors rarely use cancer prevention drugs due to concerns about side effects, costs, and effectiveness.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Certain genetic variants increase the risk of aggressive prostate cancer.

A special blood test helped find the overactive ovary in a teen with PCOS, and removing that ovary improved her condition.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Reducing out-of-pocket costs increased colorectal cancer screenings.